Analysis of therapeutic effect of recombinant human interleukin-11 combined with glucocorticoid in treatment of immune thrombocytopenia
Jing Cao,Kun Huang,Ming Xu
DOI: https://doi.org/10.3760/cma.j.issn.1673-419X.2016.01.002
2016-01-01
Abstract:Objective To investigate the efficacy and safety of recombinant human interleukin (rhIL)-11 combined with glucocorticoid in treatment of newly diagnosed immune thrombocytopenia (ITP) patients.Methods From December 2011 to December 2013,a total of 60 cases of newly diagnosed ITP patients who were received in First People's Hospital of Zhangjiagang were collected into this study.These 60 cases of ITP patients were randomly divided into two groups,as study group (n=30) and control group (n=30) by simple random samping method.The study group was used rhIL-11 combined with glucocorticoid,and control group was used glucocorticoid only.The study inclusion criteria were newly diagnosed ITP patients who were older than 18 years old.Secondary thrombocytopenia and ITP accompanied with other diseases,for example diabete,cardiac insufficiency and arrhythmia were excluded.Two groups' platelet count prior treatment,after 4 days and 7 days treatments,and average time of platelet count which is greater than or equal to 100 × 109/L were tested.Bleeding score,therapeutic efficiency evaluation and adverse reactions after 7 days treatment were calculated.The study protocol was approved by the Ethical Review Board of Investigation in Human at First People's Hospital of Zhangjiagang.Informed consent was obtained from all participants.There were no significant differences of patients' clinical data in two groups,such as age and gender composition,platelet count and bleeding score before treatment (P＞ 0.05).Results ①Platelet counts of both groups were increased gradually after treatment,but platelet count in study group [(37.9±30.4) × 109/L] was higher than that of the control group [(22.5±16.0) × 109/L] after 4 days treatment.The difference was statistically significant(t=2.308,P=0.028).Platelet count in study group[(121.8±29.2)× 109/L] was also higher than that of control group[(91.2±28.7)× 109/L] after 7 days treatment,the difference was statistically significant(t=5.444,P=0.000).In study group,the time [(7.0 ±1.4) d] that platelet count recovered greater than or equal to 100 × 109/L was shorter than that of control group [(9.3 ± 3.5) d],the difference was statistically significant (t =-3.820,P =0.001).(②) Bleeding score evaluated by ITP-bleeding assessment tool (BAT) was decreased gradually in two groups after treatment.But bleeding score of study group[(2.0±± 1.1) score] was significantly lower than that of the control group [(2.7± 1.0) score] after 4 days treatment,the difference was statistically significant(t=-2.588,P=0.015).The bleeding score of study group[(0.1 ± 0.4) score] was also significantly lower than that of the control group[(0.5 ± 1.2) score] after 7 days treatment,the difference was statistically significant(t=-2.249,P=0.032).③ The total effective rate was 90.0％ in study group,but 60.0％ in control group after 7 days treatment,and the difference was statistically significant (x2 =5.69,P＜0.05).④ In study group,6 cases(20.0％,6/30) had water-sodium retention and relieved by diuretics.Three cases (10.0 ％,3/30)had arrhythmia.2 cases(6.7 ％,2/30) had atrial premature beats noted on electrocardiogram (ECG).One case (3.3 ％,1/30) had atrial fibrillation,and recovered after injection lantoside C (cedilanid)and stopping rhIL-11 subscutaneous injection.20 cases(66.7 ％,20/30) had bulbar conjunctiva hyperemia,but needn't treatment.Among these patients,two cases in study group had two adverse affects.In control group,5 cases(16.7 ％,5/30) had slight weight gain without edema lower extremity,but needn't treatment.And 2 cases (6.7％,2/30) had sinus tachycardia,and recovered after stopping rhIL-11 subscutaneous injection.Others had no adverse affects.Conclusions rhIL-11 combined with glucocorticoid therapeutic regimen for newly diagnosed ITP took action faster and had significant effect.At the same time,adverse affects were tolerable.